Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mafb
|
ENSMUSG00000074622.3 | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_160451376_160451931 | Mafb | 84588 | 0.086510 | -0.64 | 1.7e-07 | Click! |
chr2_160451158_160451352 | Mafb | 84190 | 0.087092 | -0.57 | 5.4e-06 | Click! |
chr2_160452063_160452300 | Mafb | 85116 | 0.085745 | -0.51 | 8.0e-05 | Click! |
chr2_160367843_160368077 | Mafb | 895 | 0.678013 | -0.48 | 1.8e-04 | Click! |
chr2_160367401_160367825 | Mafb | 548 | 0.829304 | -0.41 | 1.7e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_56977792_56978080 | 11.07 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2568 |
0.32 |
chr6_67161663_67162061 | 9.05 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr4_135985229_135985393 | 8.96 |
Pithd1 |
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1 |
627 |
0.51 |
chr11_107059858_107060015 | 8.26 |
Bptf |
bromodomain PHD finger transcription factor |
7046 |
0.17 |
chr5_124052205_124052548 | 7.82 |
Gm43661 |
predicted gene 43661 |
24 |
0.95 |
chr4_33467249_33467421 | 6.87 |
Gm11935 |
predicted gene 11935 |
14446 |
0.21 |
chr11_60935403_60935625 | 6.86 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3448 |
0.16 |
chr7_55911327_55911705 | 6.77 |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
3144 |
0.16 |
chr17_47909349_47909983 | 6.72 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr10_127508848_127510720 | 6.71 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr6_38900298_38900449 | 6.53 |
Tbxas1 |
thromboxane A synthase 1, platelet |
18607 |
0.18 |
chr11_102375203_102375512 | 6.36 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
1663 |
0.21 |
chr14_14351950_14353283 | 6.28 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr7_79271113_79271304 | 6.26 |
Gm31510 |
predicted gene, 31510 |
1603 |
0.26 |
chr4_45483725_45483909 | 6.20 |
Shb |
src homology 2 domain-containing transforming protein B |
1015 |
0.5 |
chr3_93469654_93469962 | 6.19 |
Tchhl1 |
trichohyalin-like 1 |
1054 |
0.33 |
chr8_122329580_122330425 | 6.17 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr12_111516879_111517219 | 6.11 |
Gm40578 |
predicted gene, 40578 |
16209 |
0.1 |
chr4_151730005_151730352 | 6.10 |
Camta1 |
calmodulin binding transcription activator 1 |
131472 |
0.05 |
chr4_40139871_40140078 | 6.06 |
Aco1 |
aconitase 1 |
3107 |
0.25 |
chr1_167384256_167384453 | 6.04 |
Mgst3 |
microsomal glutathione S-transferase 3 |
9487 |
0.15 |
chr10_61412962_61413255 | 5.96 |
Nodal |
nodal |
4864 |
0.13 |
chr19_6291067_6291820 | 5.90 |
Ehd1 |
EH-domain containing 1 |
2738 |
0.11 |
chr6_5155538_5155858 | 5.83 |
Pon1 |
paraoxonase 1 |
38065 |
0.14 |
chr5_67815801_67816118 | 5.76 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
106 |
0.95 |
chr17_83659006_83659302 | 5.74 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
27259 |
0.19 |
chr5_123094499_123094681 | 5.68 |
Tmem120b |
transmembrane protein 120B |
5311 |
0.1 |
chr2_132575726_132575968 | 5.66 |
Gpcpd1 |
glycerophosphocholine phosphodiesterase 1 |
2286 |
0.26 |
chr12_82237150_82237498 | 5.65 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
19261 |
0.23 |
chr8_111312693_111312982 | 5.57 |
Mlkl |
mixed lineage kinase domain-like |
3282 |
0.18 |
chr5_97022388_97022894 | 5.57 |
Gm43145 |
predicted gene 43145 |
23540 |
0.12 |
chr16_92399556_92400502 | 5.55 |
Rcan1 |
regulator of calcineurin 1 |
48 |
0.97 |
chr2_121036499_121036885 | 5.54 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr1_86160075_86160340 | 5.48 |
Armc9 |
armadillo repeat containing 9 |
5388 |
0.14 |
chr13_104041138_104041339 | 5.47 |
Nln |
neurolysin (metallopeptidase M3 family) |
3596 |
0.26 |
chr14_118750627_118750802 | 5.44 |
Gm27198 |
predicted gene 27198 |
15569 |
0.15 |
chr8_35564084_35564246 | 5.39 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
23633 |
0.16 |
chr14_32164269_32164594 | 5.37 |
Ncoa4 |
nuclear receptor coactivator 4 |
1158 |
0.33 |
chrX_143011915_143012211 | 5.36 |
Ammecr1 |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
45335 |
0.15 |
chr11_107059660_107059829 | 5.35 |
Bptf |
bromodomain PHD finger transcription factor |
6854 |
0.17 |
chr16_91441869_91442151 | 5.35 |
Gm46562 |
predicted gene, 46562 |
16411 |
0.09 |
chr10_80332467_80332839 | 5.33 |
Reep6 |
receptor accessory protein 6 |
2451 |
0.1 |
chr11_20916554_20916845 | 5.33 |
Gm23681 |
predicted gene, 23681 |
21002 |
0.18 |
chr12_69367557_69367877 | 5.31 |
Gm18113 |
predicted gene, 18113 |
2306 |
0.15 |
chr15_36338833_36339076 | 5.31 |
Gm33936 |
predicted gene, 33936 |
10800 |
0.13 |
chr4_140684434_140684601 | 5.30 |
Gm13025 |
predicted gene 13025 |
4764 |
0.14 |
chr11_117781539_117781824 | 5.18 |
Tmc8 |
transmembrane channel-like gene family 8 |
395 |
0.49 |
chr17_84922055_84922228 | 5.18 |
Gm49982 |
predicted gene, 49982 |
19572 |
0.15 |
chr19_32476509_32476672 | 5.17 |
Minpp1 |
multiple inositol polyphosphate histidine phosphatase 1 |
9179 |
0.14 |
chr2_91045957_91046231 | 5.13 |
Rapsn |
receptor-associated protein of the synapse |
3309 |
0.13 |
chr10_41006809_41006996 | 5.12 |
Gm48057 |
predicted gene, 48057 |
28293 |
0.15 |
chr2_38536332_38536674 | 5.12 |
Gm35808 |
predicted gene, 35808 |
796 |
0.52 |
chr5_150135611_150135930 | 5.10 |
Fry |
FRY microtubule binding protein |
17103 |
0.18 |
chr16_87713119_87713319 | 5.07 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
14215 |
0.2 |
chr11_83224251_83224525 | 5.07 |
Gm11427 |
predicted gene 11427 |
66 |
0.72 |
chr19_40769316_40769607 | 5.05 |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
4909 |
0.21 |
chr18_3270627_3271079 | 5.04 |
Crem |
cAMP responsive element modulator |
10225 |
0.22 |
chr10_24822375_24822574 | 5.03 |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
9332 |
0.19 |
chr14_41006934_41007287 | 5.03 |
Prxl2a |
peroxiredoxin like 2A |
134 |
0.96 |
chr17_47617274_47617581 | 4.98 |
Kpna2-ps |
Kpna2 retrotransposed pseudogene |
4912 |
0.1 |
chr2_118658372_118658729 | 4.97 |
Pak6 |
p21 (RAC1) activated kinase 6 |
4753 |
0.16 |
chr6_116286832_116287192 | 4.95 |
Zfand4 |
zinc finger, AN1-type domain 4 |
459 |
0.75 |
chr5_96921434_96921585 | 4.90 |
Gm8013 |
predicted gene 8013 |
237 |
0.75 |
chr5_129000807_129001084 | 4.87 |
Stx2 |
syntaxin 2 |
1310 |
0.46 |
chr11_97435561_97436362 | 4.87 |
Arhgap23 |
Rho GTPase activating protein 23 |
324 |
0.87 |
chr7_135813684_135813871 | 4.86 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
39905 |
0.12 |
chr7_110916018_110916286 | 4.83 |
Mrvi1 |
MRV integration site 1 |
7551 |
0.17 |
chr13_81852671_81852937 | 4.83 |
Cetn3 |
centrin 3 |
60827 |
0.11 |
chr1_91278564_91278726 | 4.82 |
Ube2f |
ubiquitin-conjugating enzyme E2F (putative) |
2534 |
0.19 |
chr11_58352919_58353070 | 4.81 |
Sh3bp5l |
SH3 binding domain protein 5 like |
7682 |
0.1 |
chr3_104632973_104633136 | 4.80 |
Gm43582 |
predicted gene 43582 |
1603 |
0.22 |
chr2_153560652_153561518 | 4.80 |
Nol4l |
nucleolar protein 4-like |
31114 |
0.15 |
chr4_93583488_93583704 | 4.80 |
Gm12640 |
predicted gene 12640 |
15590 |
0.19 |
chr9_66988610_66988849 | 4.79 |
Gm24225 |
predicted gene, 24225 |
7544 |
0.16 |
chr17_84153009_84153180 | 4.79 |
Gm19696 |
predicted gene, 19696 |
3332 |
0.21 |
chrX_75115730_75115912 | 4.79 |
Mpp1 |
membrane protein, palmitoylated |
2027 |
0.19 |
chr12_111353338_111354089 | 4.77 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr16_49777328_49777597 | 4.76 |
Gm15518 |
predicted gene 15518 |
21408 |
0.2 |
chr3_14878644_14878831 | 4.74 |
Car2 |
carbonic anhydrase 2 |
7536 |
0.19 |
chr2_136920981_136921193 | 4.70 |
Slx4ip |
SLX4 interacting protein |
15544 |
0.17 |
chr7_75863314_75863477 | 4.69 |
Klhl25 |
kelch-like 25 |
14954 |
0.22 |
chr13_23270215_23270469 | 4.69 |
Vmn1r-ps135 |
vomeronasal 1 receptor, pseudogene 135 |
1462 |
0.19 |
chr19_57894175_57894549 | 4.68 |
Mir5623 |
microRNA 5623 |
156805 |
0.04 |
chr13_96971843_96972192 | 4.67 |
Gm48597 |
predicted gene, 48597 |
21103 |
0.14 |
chr13_34659657_34659903 | 4.62 |
Pxdc1 |
PX domain containing 1 |
6294 |
0.13 |
chr16_77028015_77028313 | 4.60 |
Usp25 |
ubiquitin specific peptidase 25 |
14377 |
0.21 |
chr13_95679133_95679359 | 4.54 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
3078 |
0.18 |
chrX_93831605_93832731 | 4.53 |
Pdk3 |
pyruvate dehydrogenase kinase, isoenzyme 3 |
33 |
0.98 |
chr8_22391133_22391312 | 4.53 |
Slc25a15 |
solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 |
7322 |
0.11 |
chr19_46905032_46905199 | 4.51 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
4460 |
0.2 |
chr1_152817059_152817770 | 4.51 |
Ncf2 |
neutrophil cytosolic factor 2 |
6155 |
0.16 |
chr15_103252000_103252244 | 4.51 |
Nfe2 |
nuclear factor, erythroid derived 2 |
435 |
0.71 |
chr1_88109131_88109476 | 4.51 |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
2441 |
0.1 |
chr1_23335409_23335710 | 4.50 |
Gm20954 |
predicted gene, 20954 |
11040 |
0.15 |
chr3_65658208_65659857 | 4.47 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr12_54162465_54163130 | 4.47 |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
41063 |
0.13 |
chr4_62431601_62431846 | 4.46 |
Rnf183 |
ring finger protein 183 |
3003 |
0.16 |
chr9_98299297_98299586 | 4.45 |
Gm28530 |
predicted gene 28530 |
2209 |
0.3 |
chr10_24823379_24823540 | 4.45 |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
8347 |
0.2 |
chr12_40949707_40949877 | 4.44 |
Gm18246 |
predicted gene, 18246 |
32504 |
0.14 |
chr10_77211333_77211524 | 4.44 |
Col18a1 |
collagen, type XVIII, alpha 1 |
44880 |
0.11 |
chr12_32308163_32308329 | 4.43 |
Gm33308 |
predicted gene, 33308 |
61916 |
0.1 |
chr2_173152448_173152646 | 4.43 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
501 |
0.77 |
chr5_129977865_129978035 | 4.40 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
956 |
0.4 |
chr11_120902514_120902732 | 4.40 |
Ccdc57 |
coiled-coil domain containing 57 |
16712 |
0.11 |
chr5_97007576_97007868 | 4.40 |
Bmp2k |
BMP2 inducible kinase |
10033 |
0.14 |
chr5_32717719_32717880 | 4.40 |
Gm2420 |
predicted gene 2420 |
2531 |
0.16 |
chr6_120832115_120832382 | 4.38 |
Bcl2l13 |
BCL2-like 13 (apoptosis facilitator) |
3964 |
0.17 |
chr19_46038782_46039575 | 4.37 |
Ldb1 |
LIM domain binding 1 |
303 |
0.84 |
chr4_154911160_154911660 | 4.37 |
Prxl2b |
peroxiredoxin like 2B |
12275 |
0.11 |
chr17_63261844_63262284 | 4.36 |
4930405O22Rik |
RIKEN cDNA 4930405O22 gene |
50907 |
0.13 |
chr10_8037913_8038845 | 4.36 |
Gm48614 |
predicted gene, 48614 |
17087 |
0.23 |
chr11_120630106_120630318 | 4.35 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
64 |
0.9 |
chr6_91146547_91147358 | 4.35 |
Hdac11 |
histone deacetylase 11 |
9713 |
0.13 |
chr4_108990164_108990336 | 4.34 |
Gm23589 |
predicted gene, 23589 |
8456 |
0.13 |
chr11_115911092_115911332 | 4.34 |
Smim6 |
small integral membrane protein 6 |
805 |
0.41 |
chr11_117194546_117194718 | 4.33 |
Septin9 |
septin 9 |
5029 |
0.18 |
chr9_66894964_66895296 | 4.31 |
Rab8b |
RAB8B, member RAS oncogene family |
24557 |
0.13 |
chr2_172291094_172291277 | 4.31 |
Gm14275 |
predicted gene 14275 |
3052 |
0.21 |
chrX_101376320_101376511 | 4.31 |
Gjb1 |
gap junction protein, beta 1 |
37 |
0.97 |
chr7_90042519_90042690 | 4.26 |
Gm44861 |
predicted gene 44861 |
93 |
0.95 |
chr7_27449324_27449509 | 4.26 |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
1355 |
0.23 |
chr4_130173547_130173713 | 4.23 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
1061 |
0.47 |
chrX_12312513_12312900 | 4.22 |
Gm14635 |
predicted gene 14635 |
32516 |
0.21 |
chr2_79763133_79763311 | 4.19 |
Ppp1r1c |
protein phosphatase 1, regulatory inhibitor subunit 1C |
23369 |
0.25 |
chr11_77983926_77984968 | 4.19 |
Phf12 |
PHD finger protein 12 |
1645 |
0.25 |
chr5_121242758_121242924 | 4.19 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
22622 |
0.12 |
chr1_88140573_88140785 | 4.17 |
Ugt1a6a |
UDP glucuronosyltransferase 1 family, polypeptide A6A |
2301 |
0.1 |
chr10_94931912_94932258 | 4.16 |
Plxnc1 |
plexin C1 |
9428 |
0.21 |
chr2_152814637_152814795 | 4.15 |
Bcl2l1 |
BCL2-like 1 |
13819 |
0.12 |
chr10_94020675_94020940 | 4.14 |
Vezt |
vezatin, adherens junctions transmembrane protein |
84 |
0.95 |
chr17_74491702_74491860 | 4.14 |
Yipf4 |
Yip1 domain family, member 4 |
63 |
0.97 |
chr19_36451049_36451311 | 4.14 |
F530104D19Rik |
RIKEN cDNA F530104D19 gene |
23 |
0.98 |
chr4_107458953_107459287 | 4.13 |
Glis1 |
GLIS family zinc finger 1 |
20122 |
0.16 |
chr8_111742224_111742902 | 4.12 |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
1246 |
0.46 |
chr11_75651168_75652336 | 4.12 |
Myo1c |
myosin IC |
242 |
0.88 |
chr14_20599676_20599956 | 4.10 |
Usp54 |
ubiquitin specific peptidase 54 |
5514 |
0.13 |
chr6_149194117_149194285 | 4.09 |
Amn1 |
antagonist of mitotic exit network 1 |
5489 |
0.16 |
chr13_14033395_14033670 | 4.08 |
Tbce |
tubulin-specific chaperone E |
6047 |
0.13 |
chr11_85803442_85803612 | 4.08 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
628 |
0.57 |
chr11_80171924_80172132 | 4.08 |
Adap2os |
ArfGAP with dual PH domains 2, opposite strand |
5601 |
0.15 |
chr7_142568972_142569582 | 4.06 |
H19 |
H19, imprinted maternally expressed transcript |
7261 |
0.1 |
chr3_137969141_137969487 | 4.05 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12216 |
0.12 |
chr13_45547019_45547393 | 4.05 |
Gmpr |
guanosine monophosphate reductase |
1053 |
0.63 |
chr8_13203181_13203506 | 4.04 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
2523 |
0.15 |
chr7_103860925_103861255 | 4.04 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
7874 |
0.06 |
chr6_72099442_72099645 | 4.03 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
1786 |
0.23 |
chr19_24794396_24794754 | 4.01 |
Pgm5 |
phosphoglucomutase 5 |
31497 |
0.16 |
chr6_72357679_72357987 | 4.01 |
Tmem150a |
transmembrane protein 150A |
1607 |
0.2 |
chr17_72839097_72839276 | 4.00 |
Ypel5 |
yippee like 5 |
815 |
0.73 |
chr14_69540059_69540582 | 4.00 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr14_69321815_69322332 | 3.99 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr5_123035606_123035824 | 3.98 |
Gm43412 |
predicted gene 43412 |
285 |
0.79 |
chr16_92764789_92765070 | 3.97 |
Runx1 |
runt related transcription factor 1 |
60849 |
0.13 |
chr4_98190095_98190255 | 3.97 |
Gm12691 |
predicted gene 12691 |
39914 |
0.15 |
chr4_76344171_76344337 | 3.97 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
11 |
0.99 |
chr10_42518451_42518631 | 3.96 |
Snx3 |
sorting nexin 3 |
16251 |
0.18 |
chr1_185071582_185071871 | 3.96 |
Gm34732 |
predicted gene, 34732 |
14238 |
0.15 |
chr16_11270757_11270983 | 3.95 |
Mir1945 |
microRNA 1945 |
16425 |
0.12 |
chr18_15276885_15277042 | 3.95 |
E430002N23Rik |
RIKEN cDNA E430002N23 gene |
35736 |
0.16 |
chr14_31496290_31496601 | 3.94 |
Eaf1 |
ELL associated factor 1 |
1249 |
0.3 |
chr7_119280318_119280619 | 3.93 |
Gm4083 |
predicted gene 4083 |
21239 |
0.18 |
chr15_38543513_38543843 | 3.93 |
Azin1 |
antizyme inhibitor 1 |
24412 |
0.1 |
chr4_119028467_119028820 | 3.92 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr5_115945538_115945746 | 3.92 |
Cit |
citron |
345 |
0.86 |
chr9_32098893_32099046 | 3.91 |
Arhgap32 |
Rho GTPase activating protein 32 |
17167 |
0.15 |
chr5_93290268_93290448 | 3.91 |
Ccng2 |
cyclin G2 |
21650 |
0.17 |
chr2_84059340_84059550 | 3.91 |
Gm13692 |
predicted gene 13692 |
24832 |
0.14 |
chr4_137751768_137751925 | 3.90 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
4699 |
0.21 |
chr12_79604790_79605118 | 3.89 |
Rad51b |
RAD51 paralog B |
277601 |
0.01 |
chr19_55257565_55258057 | 3.89 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
4442 |
0.2 |
chr18_4944500_4944794 | 3.89 |
Svil |
supervillin |
22921 |
0.26 |
chr15_95883474_95883993 | 3.89 |
Gm25070 |
predicted gene, 25070 |
3916 |
0.23 |
chr6_3265625_3265784 | 3.88 |
Gm42961 |
predicted gene 42961 |
11849 |
0.12 |
chr13_96742964_96743239 | 3.88 |
Ankrd31 |
ankyrin repeat domain 31 |
5171 |
0.2 |
chr12_40027574_40027739 | 3.88 |
Arl4a |
ADP-ribosylation factor-like 4A |
9711 |
0.19 |
chr4_62383795_62384159 | 3.87 |
Slc31a1 |
solute carrier family 31, member 1 |
1524 |
0.29 |
chr19_10015993_10016160 | 3.87 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
1032 |
0.39 |
chr15_78318816_78319112 | 3.87 |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
6788 |
0.12 |
chr13_73472597_73472776 | 3.86 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
935 |
0.62 |
chr5_90696198_90696349 | 3.86 |
Gm43090 |
predicted gene 43090 |
54252 |
0.08 |
chr7_84651782_84651977 | 3.85 |
Zfand6 |
zinc finger, AN1-type domain 6 |
17540 |
0.16 |
chr10_43630601_43630939 | 3.85 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
7023 |
0.14 |
chr16_35905930_35906086 | 3.83 |
Gm10237 |
predicted gene 10237 |
14456 |
0.1 |
chr2_69818525_69818680 | 3.83 |
Klhl23 |
kelch-like 23 |
3342 |
0.14 |
chr6_115666689_115667030 | 3.83 |
Raf1 |
v-raf-leukemia viral oncogene 1 |
9105 |
0.12 |
chr11_74831594_74833056 | 3.83 |
Mnt |
max binding protein |
1405 |
0.31 |
chr3_103197133_103197315 | 3.82 |
2410024N13Rik |
RIKEN cDNA 2410024N13 gene |
1751 |
0.27 |
chr7_35448610_35448793 | 3.82 |
Slc7a9 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 |
95 |
0.95 |
chr11_100719320_100719626 | 3.81 |
Hspb9 |
heat shock protein, alpha-crystallin-related, B9 |
5551 |
0.09 |
chr4_129256465_129256870 | 3.80 |
C77080 |
expressed sequence C77080 |
4737 |
0.13 |
chr17_25127091_25127504 | 3.80 |
Clcn7 |
chloride channel, voltage-sensitive 7 |
6094 |
0.1 |
chr19_11727383_11727597 | 3.79 |
Cblif |
cobalamin binding intrinsic factor |
20064 |
0.08 |
chr13_4206238_4206406 | 3.79 |
Akr1c13 |
aldo-keto reductase family 1, member C13 |
12464 |
0.13 |
chr6_57745472_57745766 | 3.78 |
Lancl2 |
LanC (bacterial lantibiotic synthetase component C)-like 2 |
42532 |
0.09 |
chr15_82184680_82184902 | 3.78 |
Gm49502 |
predicted gene, 49502 |
725 |
0.46 |
chr2_158144372_158144546 | 3.76 |
Tgm2 |
transglutaminase 2, C polypeptide |
1907 |
0.28 |
chr18_6760941_6761115 | 3.76 |
Gm7466 |
predicted gene 7466 |
69 |
0.97 |
chr11_3170338_3170795 | 3.75 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
138 |
0.93 |
chr6_67149473_67149848 | 3.75 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
15264 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 5.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.8 | 5.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.8 | 5.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.8 | 5.3 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.7 | 8.4 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.7 | 5.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.6 | 4.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.6 | 4.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.4 | 4.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.4 | 5.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.3 | 3.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 1.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.2 | 4.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.2 | 1.2 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.2 | 3.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.2 | 3.6 | GO:0036394 | amylase secretion(GO:0036394) |
1.2 | 3.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.2 | 3.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.2 | 9.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.2 | 4.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.2 | 3.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.1 | 3.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.1 | 3.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.1 | 3.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 3.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.1 | 4.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.0 | 3.0 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 7.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.0 | 4.0 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
1.0 | 3.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.0 | 2.9 | GO:0042938 | dipeptide transport(GO:0042938) |
1.0 | 3.9 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
1.0 | 3.9 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.0 | 2.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.0 | 2.9 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.0 | 4.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.9 | 3.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.9 | 2.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.9 | 2.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.9 | 2.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 3.5 | GO:0097286 | iron ion import(GO:0097286) |
0.9 | 2.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.9 | 2.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.9 | 2.6 | GO:0015677 | copper ion import(GO:0015677) |
0.8 | 1.7 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.8 | 2.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.8 | 2.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.8 | 2.5 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.8 | 1.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 2.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.8 | 4.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.8 | 2.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.8 | 8.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.8 | 7.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.8 | 4.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.8 | 4.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 3.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.7 | 2.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 2.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 2.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 2.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 2.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.7 | 1.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.7 | 2.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 2.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.7 | 2.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.7 | 2.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.7 | 3.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.7 | 1.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.7 | 3.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 2.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.7 | 2.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.7 | 2.8 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.7 | 1.4 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.7 | 2.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 2.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 1.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.7 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.7 | 0.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.7 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 2.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.7 | 2.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.7 | 5.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.7 | 3.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 2.6 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.7 | 2.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.6 | 0.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.6 | 4.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.6 | 1.2 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.6 | 14.7 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 0.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.6 | 2.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.6 | 1.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.6 | 1.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.6 | 0.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.6 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 1.2 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.6 | 2.3 | GO:0009597 | detection of virus(GO:0009597) |
0.6 | 1.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.6 | 1.7 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.6 | 1.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 2.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.6 | 2.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 1.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 0.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 2.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.5 | 1.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.5 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.5 | 1.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 1.1 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 1.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 1.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 3.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 2.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 2.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 3.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 1.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 2.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 3.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.5 | 1.5 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 0.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 1.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.5 | 2.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 | 1.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 1.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 2.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 0.5 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.5 | 1.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.5 | 2.0 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 1.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.5 | 2.9 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.5 | 1.9 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.5 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.5 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 0.5 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.5 | 3.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 1.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 1.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.5 | 2.4 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.5 | 1.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 1.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 1.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 0.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.4 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 8.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 3.7 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.5 | 0.9 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 0.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 2.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 1.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 0.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.5 | 1.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.5 | 1.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 0.4 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.4 | 2.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 4.0 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.4 | 1.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 2.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 0.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 0.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 3.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.4 | 1.3 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 1.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.4 | 2.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.4 | 2.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 1.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 4.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 1.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 3.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 1.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 2.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 0.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 3.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 8.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 1.7 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.4 | 1.3 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.4 | 0.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 1.3 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.4 | 0.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.4 | 1.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 1.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 2.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 1.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 0.8 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.4 | 4.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 1.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 0.4 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.4 | 2.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 1.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 3.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 1.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 3.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.4 | 3.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 1.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.4 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 2.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.4 | 3.9 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.4 | 1.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 0.8 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.4 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 0.4 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 1.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 3.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 1.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 2.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 2.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 1.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 5.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 1.9 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 3.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 1.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 1.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 1.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 2.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 3.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 1.4 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.4 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.4 | 0.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.4 | 1.4 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.4 | 0.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 0.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.4 | 1.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 0.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.4 | 0.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 1.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 1.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 0.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 2.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 0.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 4.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 2.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.3 | 1.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 1.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 2.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 0.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 0.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 1.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 1.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.3 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 1.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 3.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 2.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 5.4 | GO:0002931 | response to ischemia(GO:0002931) |
0.3 | 1.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 2.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 7.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 1.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 1.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 1.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.3 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.3 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 2.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 1.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 1.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.3 | 1.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 2.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 0.6 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.3 | 1.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 2.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 1.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 1.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 1.6 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 1.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 3.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 0.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 0.6 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.3 | 0.6 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 4.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.3 | 0.6 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.6 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.3 | 0.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 1.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 2.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.3 | 2.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 1.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 3.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.3 | 1.8 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.9 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 2.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 1.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.6 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.3 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.3 | 0.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 1.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 0.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 1.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 1.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.3 | 1.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.9 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 2.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.3 | 4.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 3.5 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 0.3 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.3 | 0.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 3.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.6 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.3 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.6 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 5.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 2.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 1.7 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 0.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.3 | 0.6 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.3 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 1.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 0.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 1.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 1.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.3 | 1.7 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 3.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 2.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 3.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 4.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 2.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.3 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.3 | 0.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.3 | 1.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 2.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 1.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 5.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.3 | 1.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 0.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 0.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 1.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 0.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 2.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.3 | 0.5 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.3 | 1.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 0.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 3.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 0.8 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 1.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 0.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 3.4 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.3 | 1.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 1.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 0.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.3 | 0.8 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.3 | 1.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 0.5 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 0.5 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.3 | 1.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 0.5 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 3.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 1.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 2.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 1.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 1.5 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 1.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 1.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 0.3 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.3 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 0.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 0.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 2.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 0.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 0.8 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 0.3 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.2 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 1.0 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 3.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 1.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.2 | 0.2 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.2 | 0.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 1.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 2.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 4.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.5 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 3.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 1.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 1.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.9 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 2.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 1.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 1.0 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 0.5 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 2.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.5 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 1.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 1.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 1.9 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 2.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.7 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.7 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 2.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.7 | GO:0051610 | serotonin uptake(GO:0051610) |
0.2 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 1.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 1.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 1.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 1.8 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.5 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.9 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 1.6 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 1.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.2 | 0.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 5.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.4 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 2.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.9 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 1.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 2.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 1.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 1.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 0.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 1.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 1.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 1.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.4 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.2 | 0.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 2.9 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 1.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 5.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 2.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 1.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.2 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.2 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 1.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.2 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.2 | 2.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 2.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.2 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of forebrain neuron differentiation(GO:2000978) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.2 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 3.6 | GO:0032608 | interferon-beta production(GO:0032608) |
0.2 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 0.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 0.4 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 0.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 0.6 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 1.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 1.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 2.5 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.2 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 1.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.6 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 2.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 3.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.6 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.2 | 0.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.2 | GO:1904749 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 1.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 1.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 7.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 1.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.6 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.4 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.2 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 1.1 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.2 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 1.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 3.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.5 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 2.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.2 | 0.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.2 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.2 | 2.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.4 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.5 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.5 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 1.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.2 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 2.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 4.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 1.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 2.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.7 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 2.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.8 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.2 | 0.3 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.2 | 0.7 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.2 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.2 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 1.5 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.3 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.2 | 0.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.2 | 1.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.2 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 0.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 1.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.5 | GO:0001774 | microglial cell activation(GO:0001774) |
0.2 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.8 | GO:0072537 | fibroblast activation(GO:0072537) |
0.2 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.2 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.2 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.2 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 1.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 3.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.2 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.2 | 1.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 1.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.8 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.6 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.6 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.3 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.2 | 2.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 1.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 2.6 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 1.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 1.4 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.8 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.4 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.1 | GO:0043307 | eosinophil activation(GO:0043307) |
0.1 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 2.9 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 2.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 1.2 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 2.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 2.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 1.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.1 | 0.7 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 1.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.3 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.4 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.1 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 2.0 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.4 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 2.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.4 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 1.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 1.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.8 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 1.1 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.6 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.1 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 3.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 4.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.3 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.4 | GO:0015793 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.1 | 0.4 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 1.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 1.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.2 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.8 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 1.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 1.1 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 3.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 1.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.7 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.4 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.4 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 0.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.9 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 1.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 3.1 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.5 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.5 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 3.1 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.1 | 0.5 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.5 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 1.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.5 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.6 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.1 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.2 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.1 | 0.6 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 1.6 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 1.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 1.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.8 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 1.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 1.8 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.5 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 1.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 1.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 1.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 1.9 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.1 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 1.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 6.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 1.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 1.8 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.7 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 0.6 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.9 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 1.0 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 4.9 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.1 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 2.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 2.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.4 | GO:0051256 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 1.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.7 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 2.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 3.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 0.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 1.0 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 1.0 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.7 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 2.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 1.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.5 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 0.8 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.6 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.2 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 3.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.4 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.1 | 0.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.4 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.3 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.1 | 1.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 1.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.1 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.2 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.3 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 3.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 1.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.1 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 4.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.2 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 1.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.7 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 1.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.9 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.1 | 0.5 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 3.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:1903310 | positive regulation of chromatin modification(GO:1903310) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.8 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.6 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 2.4 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.4 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 0.6 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 1.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.3 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.4 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.5 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.8 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.1 | 0.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.6 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.4 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.1 | 0.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.8 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.4 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.2 | GO:1900426 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.1 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 4.4 | GO:0007596 | blood coagulation(GO:0007596) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.4 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.1 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.1 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.1 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.1 | GO:0072604 | interleukin-6 secretion(GO:0072604) |
0.1 | 1.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 1.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.8 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 1.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.2 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.7 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.5 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 1.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 1.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0044321 | response to leptin(GO:0044321) |
0.0 | 0.3 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 1.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 1.4 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.3 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 9.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.4 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 1.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 1.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.2 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.0 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.0 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0009262 | deoxyribonucleotide metabolic process(GO:0009262) |
0.0 | 0.0 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 1.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.2 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.2 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.0 | 0.1 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.0 | 0.5 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.6 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.0 | 0.2 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 3.6 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.0 | 0.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.3 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.6 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.2 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.0 | 0.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.0 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 2.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.2 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 3.3 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.0 | 0.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.0 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.0 | 0.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.2 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.5 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.0 | 0.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0050706 | regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 1.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 2.8 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0048232 | male gamete generation(GO:0048232) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.0 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.0 | 0.2 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.0 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 6.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.1 | 4.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.0 | 4.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.0 | 8.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.0 | 5.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.0 | 4.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.9 | 4.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 2.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.9 | 2.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.8 | 3.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 4.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 3.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 3.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 2.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 4.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 1.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 3.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 3.3 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 1.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.6 | 3.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 1.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.6 | 1.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 1.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 1.5 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 1.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 1.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 1.5 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 3.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 2.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.5 | 1.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 1.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 0.9 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 1.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 2.2 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 2.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 1.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 1.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 1.2 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 17.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 1.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 1.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 2.2 | GO:0005818 | aster(GO:0005818) |
0.4 | 1.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 1.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 2.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 1.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 2.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 2.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 1.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 2.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 1.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 1.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 1.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 2.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 3.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 3.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 1.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 1.6 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 3.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 4.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 21.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 2.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 4.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 2.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 3.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 1.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 2.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 4.7 | GO:0043034 | costamere(GO:0043034) |
0.3 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 19.1 | GO:0016605 | PML body(GO:0016605) |
0.3 | 4.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 11.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 11.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 3.8 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 4.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.3 | 2.5 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 16.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 2.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 3.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 10.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 2.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.3 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 3.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 2.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 1.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.3 | GO:0031430 | M band(GO:0031430) |
0.3 | 3.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 3.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 8.3 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 5.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 5.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 1.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 11.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 11.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.1 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 2.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 2.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 4.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 2.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 4.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 8.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 2.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 2.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 9.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 3.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 4.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 6.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 3.6 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 5.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 2.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 23.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 5.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 2.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 6.5 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.6 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 4.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 3.7 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.7 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 13.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 6.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 6.7 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.6 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 9.6 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.8 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 13.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 2.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 4.9 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 5.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 5.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 5.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 6.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 2.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.3 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.1 | 4.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 3.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 2.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 3.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.9 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 39.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 4.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 3.1 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 0.8 | GO:0001741 | XY body(GO:0001741) |
0.1 | 29.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 2.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 2.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 11.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 2.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 3.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 2.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.3 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 2.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 2.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 79.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 5.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 17.3 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 2.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 2.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 3.7 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.8 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.9 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.1 | 1.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.4 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 2.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 14.5 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 2.2 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 1.0 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.5 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 7.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 36.7 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 39.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.3 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 9.5 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 1.7 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 10.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 1.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.0 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.0 | 20.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 2.0 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.3 | GO:0043205 | fibril(GO:0043205) |
0.0 | 2.8 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 32.1 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 2.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.1 | 8.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.5 | 4.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.4 | 9.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.4 | 5.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.3 | 4.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 5.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.3 | 3.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.1 | 3.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 1.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
1.1 | 4.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.1 | 4.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.0 | 6.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 2.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 7.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.9 | 6.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.8 | 2.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 2.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.8 | 4.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.8 | 2.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.8 | 3.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 3.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.8 | 2.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 3.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 4.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 2.3 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 2.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.7 | 3.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.7 | 5.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 0.7 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.7 | 2.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.7 | 2.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 2.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 4.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.7 | 0.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.7 | 2.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.7 | 2.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.7 | 0.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.6 | 1.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 2.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 3.7 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 1.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 3.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 1.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.6 | 2.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 4.2 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.6 | 2.9 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.6 | 2.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.5 | 3.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 1.6 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 1.6 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 2.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 7.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 2.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 2.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.5 | 1.0 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.5 | 1.0 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.5 | 1.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.5 | 2.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 1.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 5.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 1.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 1.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 3.9 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.5 | 1.5 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.5 | 1.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 3.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 2.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 1.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 1.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 2.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 1.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 0.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.5 | 1.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 3.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 1.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 1.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 2.3 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 1.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 2.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 2.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 1.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 2.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.4 | 6.1 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 3.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 0.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.4 | 1.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.4 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 2.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 2.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 3.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 0.4 | GO:0005048 | signal sequence binding(GO:0005048) |
0.4 | 1.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 0.4 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.4 | 1.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 0.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 1.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 4.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 3.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 7.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 0.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.4 | 2.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.4 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 2.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 3.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 1.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 3.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.4 | 2.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 3.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 3.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 2.6 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 3.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 3.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 1.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 2.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 2.5 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 4.3 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.4 | 1.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 2.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 2.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.8 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 3.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 1.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 1.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 2.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 4.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 2.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 1.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 4.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 2.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 2.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 1.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 3.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 0.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 2.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 3.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 2.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 2.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 4.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 1.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 0.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.3 | 0.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 4.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 1.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 2.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.3 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 3.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 0.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 1.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 8.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 3.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 1.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 1.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 6.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 3.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 5.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 0.8 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 3.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 0.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.3 | GO:0044606 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.3 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 0.8 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 0.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.3 | 1.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 2.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 3.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 1.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.2 | GO:0016972 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.2 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 2.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 4.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 2.2 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.2 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.2 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.2 | 3.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 4.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 3.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 2.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 7.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 4.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 3.0 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 1.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 4.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 3.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 6.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 2.7 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 9.7 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.2 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 3.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 2.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 2.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 1.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 2.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 2.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 5.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 1.3 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.2 | 1.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 2.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 16.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 4.3 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.2 | 2.6 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 4.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.2 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.2 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 2.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 2.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 9.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 4.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 1.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.2 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 1.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.3 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 5.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 5.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 1.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 6.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 3.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 5.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 5.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 3.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 14.3 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 1.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 3.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 2.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 1.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 2.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 16.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 0.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 4.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.8 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 1.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 2.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.5 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 6.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 2.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 1.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 7.3 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 3.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 2.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 2.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.2 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 5.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 3.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 1.6 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 1.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 2.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 3.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.8 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 2.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 9.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.8 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 3.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.9 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 9.0 | GO:0043492 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 3.3 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 8.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 3.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 2.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 1.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 1.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 3.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 21.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 14.3 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 2.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.5 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 1.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 3.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 5.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 2.4 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.9 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 3.3 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.7 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 2.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.7 | GO:0052686 | acyl-CoA ligase activity(GO:0003996) succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.4 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 1.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 1.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 3.1 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 1.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.4 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 2.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 4.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 1.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 2.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 2.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 2.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 2.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 2.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 4.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 3.3 | GO:0060090 | binding, bridging(GO:0060090) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 3.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 10.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 2.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.6 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 1.4 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 1.4 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 10.3 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.5 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 2.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 16.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 2.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 2.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.6 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.3 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.5 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.3 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 2.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 1.8 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 3.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 1.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.8 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 2.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 6.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 2.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 3.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 1.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 1.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 1.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 1.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 1.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.5 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 1.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.9 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 3.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 2.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 3.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 1.0 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.4 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.0 | 0.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 5.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 12.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 23.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 9.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 4.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 3.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 8.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 5.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 3.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 6.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 2.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 5.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 3.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 4.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 2.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 13.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 1.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 12.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 3.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 6.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 5.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 5.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 8.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 2.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 7.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 8.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 0.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 4.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 3.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 5.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 2.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 3.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 5.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 7.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 4.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 15.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 3.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 4.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 6.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 3.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 3.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 5.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.8 | 5.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 8.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 8.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.5 | 5.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 16.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 7.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 7.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 8.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 5.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 4.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 2.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 7.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 4.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 4.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 4.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 4.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 1.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.4 | 4.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 3.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 8.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 0.4 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.4 | 3.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 2.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 3.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 4.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 6.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 4.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 1.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 4.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 4.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 2.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 1.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 7.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 4.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 5.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 4.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 7.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 6.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 4.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 24.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 7.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 2.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 1.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 5.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 2.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 1.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 7.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 4.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 2.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 3.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 19.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 3.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 6.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 3.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 5.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 10.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 9.9 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 2.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 2.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 2.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 14.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 3.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 3.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 3.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 5.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 2.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 8.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 7.2 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.2 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 3.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 2.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 1.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 1.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 1.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 1.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 1.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 3.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 6.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 4.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 3.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 2.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 4.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 2.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 1.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 0.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 1.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 3.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.8 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 4.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 16.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.3 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 5.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 10.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 3.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 3.6 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.1 | 0.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.8 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 3.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 4.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 2.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 5.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 7.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 3.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 3.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 1.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |